*********DID YOU HEAR THE NEWS?******** I  PROMISE YOU IF

New Post Public Reply Private Reply Replies (0) Message Board
WARMBUFFETT

*********DID YOU HEAR THE NEWS?********

I  PROMISE YOU IF YOU KNOW 25% OF WHAT THE AVG. INVESTOR KNOWS IF YOU TAKE THE TIME TO READ THE LAST 10 PRs AND S.E.C. FILES. YOU WILL BUY THIS STOCK. I UNDERSTAND YOU GET BOMBED WITH TRASH STOCKS EVERYDAY, I TOOK THE CHANCE AND SPENT A WHOLE 15 MINUTES READING TALKED TO THE GUYS ON THE HUB BOARD, TALKED TO THE COMPANY, ONE CONF. CALL AND I  SOLD 9 OF MY 14 STOCKS AND  BOUGHT  CDFT-QB  THIS PERFECT STORM COMES ABOUT EVERY  5 YEARS.   ANY  QUESTIONS LETS DO A 3-WAY WITH THE COMPANY. YES THATS HOW REAL COMPANYS WORK, RIGHT NOW BOOK VALUE IS .09 SHARE PRICE IS .01   THIS NEXT Q WILL TURN SOME HEADS.

 

mergers and acquisitions COMING SOON!

Citadel EFT, Inc. (OTCQB: CDFT) CEO Gary DeRoos is pleased to announce that he will be retiring 117,000,000 of his 168,000,000 common securities effective May 13th, 2013. This is two days prior to when Citadel EFT is due to post its second quarter results . The retirement of these securities on that date will effectively bring the Issued Capital to approximately 116 million shares.

 

Gary DeRoos, CEO, Citadel EFT, states, "We have retired significant amounts of compensation securities back into treasury, and the last responsibility was to retire 70% of my holdings. I will be in discussion with our other preferred stockholders who own the balance of the common to suggest retiring more of the common, so that we can bring our market capitalization more in line with the equity we are building on the balance sheet.

Zero Debt
Over 3,000,000 in Net Equity
Revenue Generation Business, $450k per annum
$250,000 in dividends paid to Gary DeRoos, Series A
Continued growth in sales of credit card processing business
The company has CASH, no going concern
It's adding more value on the balance sheet from Q to Q
It's retired it's Professional Contracts,
Management has removed all of its compensation securities
Management now intends to lower its Issued Capital
The Market Cap of the Company is way under value
Management has met with AMEX people, PRE approved
Company float has remained at 65,000,000, no new issuances
*********The Company does not pay or sanction paid for promo**************************
*********The Company is a OTCQB, not a pink sheet company**************************
**********The Company is an a SEC filer, it's information is audited**********************
***********The Company hires independent evaluators to buy assets
The Company is building a board with pedigree
The Company has been honest, every time it retired stock
The Company has made itself available to answer inquiries
The Company has done conference calls using a shareholder
The stock has come from .0011 to a high of .027 cents
The stock has traded in the penny range for the last month
The stock has been oversold, more than the size of the float
The longs are not budging from their positions

He further states, "We are extremely pleased with the improvements we are making to our balance sheet. We expect, in the next two quarters, to improve our cash position and our overall net stock holders equity. We have retired all compensation securities to management, and lowering the Issued Capital was always part of our agenda. The significance of choosing May 13th as the effective date is that it is before our second quarter results are due to be posted. And we have indicated in a previous press release that we would lower the issued capital before Q2 was posted. We are meeting that obligation, and look forward to any shareholder inquiries on the matter."   CEO  GARY 714-423-0701




Get the latest investment information from http://investorshangout.com/post/707459/DID-Y...z2QYjQNQIL

Follow me to the TRII board, 20 bagger by XMAS
BRAND NEW MILL READY TO CHEW!
Cash-Flow Positive in less than Two Q's

53225022_trio-logo-header-small.jpg
1945865170_xxl[oTRIO_Logo_.jpg

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading